This morning, Johnson & Johnson shared its second-quarter performance.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Johnson & Johnson’s second-quarter results were driven by strong performance across our three business units, exceeding expectations,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Continued market recovery favorably impacted growth comparisons as our Pharmaceutical, Medical Device and Consumer Health businesses improved their market-leading positions across many platforms. This performance underscores the resilience of our diversified business, in addition to the agility of our colleagues to meet the needs of patients and consumers around the world. We are poised to continue our pursuit of improving human health and the well-being of people around the world while delivering long-term value to all of our stakeholders well beyond 2021.”
For more details about the company’s 2021 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.
Johnson & Johnson’s 2021 2nd-Quarter Earnings
You are now leaving jnj.com
The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
